AQST Q3 2019 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$12M-6.4% YoY

Gross Profit

$8M62.6% margin

Operating Income

-$11M-88.6% margin

Net Income

-$18M-148.3% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+11.6%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$49M

Total Liabilities

$83M

Stockholders' Equity

-$34M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$13M	-6.4%
Gross Profit	$8M	$8M	+1.3%
Operating Income	-$11M	-$9M	-19.5%
Net Income	-$18M	-$15M	-22.4%

Revenue Segments

Manufacture and Supply Revenue

$9M87%

License and Royalty Revenue

$1M13%